Similarly, by neutralizing tumor B7-H3 with anti-B7-H3 antibodies, we found that cancer cells significantly increased susceptibility to OXP, leading to caspase-3 cleavage and activation in EGFR-overexpressing cells (Fig. 4C and 4D). This evidence concerns the gene CD276 and neoplasm.